Glenmark To Conduct Clinical Trials For COVID-19 Drug; Shares Surge

Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.

from NDTV Profit - Latest https://ift.tt/3f3Zhts
via